Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Barth

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
American Journal of Medical Genetics|October 21, 1999
Trisomy 2p syndrome: a fetus with anencephaly and postaxial polydactylyG K Hahm, R F Barth, G M Schauer, et al.
Neurosurgery|May 1, 1996
Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruptionW Yang, R F Barth, D E Carpenter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1970
Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharideP J Baker, P W Stashak, D F Amsbaugh, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Neurosurgery|February 5, 1999
Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7)R F Barth, W Yang, R T Bartus, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1990
Alterations in monoclonal antibody affinity and antigenic receptor site expression on mycoplasma-infected human colorectal cancer cellsO A Oredipe, R F Barth, J H Rotaru, et al.
Anticancer Research|September 1, 1996
Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Basic Life Sciences|January 1, 1990
Tumor targeting agents for neutron capture therapyA H Soloway, F Alam, R F Barth, et al.
Journal of Neuro-Oncology|May 1, 1997
The rationale and requirements for the development of boron neutron capture therapy of brain tumorsA H Soloway, R F Barth, R A Gahbauer, et al.
Anticancer Research|September 1, 1995
Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapyJ H Yong, R F Barth, J H Rotaru, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
American Journal of Medical Genetics|October 21, 1999
Trisomy 2p syndrome: a fetus with anencephaly and postaxial polydactylyG K Hahm, R F Barth, G M Schauer, et al.
Neurosurgery|May 1, 1996
Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruptionW Yang, R F Barth, D E Carpenter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1970
Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharideP J Baker, P W Stashak, D F Amsbaugh, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Neurosurgery|February 5, 1999
Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7)R F Barth, W Yang, R T Bartus, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1990
Alterations in monoclonal antibody affinity and antigenic receptor site expression on mycoplasma-infected human colorectal cancer cellsO A Oredipe, R F Barth, J H Rotaru, et al.
Anticancer Research|September 1, 1996
Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumorsL Liu, R F Barth, D M Adams, et al.
Basic Life Sciences|January 1, 1990
Tumor targeting agents for neutron capture therapyA H Soloway, F Alam, R F Barth, et al.
Journal of Neuro-Oncology|May 1, 1997
The rationale and requirements for the development of boron neutron capture therapy of brain tumorsA H Soloway, R F Barth, R A Gahbauer, et al.
Anticancer Research|September 1, 1995
Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapyJ H Yong, R F Barth, J H Rotaru, et al.
Pageof 16